The Johnson & Johnson Charts Are Healthy Enough for Further Gains

The Johnson & Johnson Charts Are Healthy Enough for Further Gains
·2 min read

During the Lightning Round segment of Monday's Mad Money program, one caller asked Jim Cramer about Johnson & Johnson : "This stock has a big development pipeline and that's why it keeps going up," he replied. With the price weakness we have seen I will assume that traders have been stopped out around $160. The On-Balance-Volume (OBV) line shows a decline from May into June telling us that some traders have become more aggressive sellers of JNJ.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting